The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, ...

Press Release Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial Several aqueous humor parameters ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Absci Corp (ABSI) reports increased R&D expenses and low revenue, but showcases promising clinical advancements and a robust cash position.

Guidance for the X-TOLE2 Phase 3 epilepsy study shifted from the second half of 2025 to "early next year," reflecting a slight timeline delay. Management's strategic focus remains on advancing ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

“When the development timeline is very limited for early filing of an investigation new drug (IND) application ... crystallization of excipients, phase separation) and compromised integrity of the ...

Columbia University, the Company's collaboration partner for pre-clinical development, granted Silo an exclusive global ...

CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, launched their novel Cardiac application today-the next key offering in its Pixel application portfolio.

The $25 million lab will handle research and development as well as quality testing for Civica’s nearby pharmaceutical plant ...

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...